A Qualitative Hybrid III Implementation Study to Identify and Evaluate
Research payments
$3,135,073
Through program year 2023, $3,135,073 in research payments was reported against A Qualitative Hybrid III Implementation Study to Identify and Evaluate, across 194 payments, paid by ViiV Healthcare Company.
- Paid by
- ViiV Healthcare Company
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $374,659 | 30 |
| 2022 | Research | $106,556 | 36 |
| 2021 | Research | $1,068,358 | 67 |
| 2020 | Research | $1,063,002 | 34 |
| 2019 | Research | $522,498 | 27 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
7 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Michael Wohlfeiler Miami Beach, FL Named on 60 payments
- Daniela Chiriboga Salazar Jacksonville, FL Named on 26 payments
- Jason Flamm Sacramento, CA Named on 16 payments
- Leandro Mena Jackson, MS Named on 11 payments
- Paul Benson Berkley, MI Named on 9 payments
- Gary Sinclair Dallas, TX Named on 8 payments
- Christine Zurawski Atlanta, GA Named on 7 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.